Sepsis & infection

Effect modification by chronic kidney disease on renal outcomes in septic shock patients undergoing high-MAP targeting: a secondary analysis of the OPTPRESS trial

J Intensive CarePublished Secondary analysis of the OPTPRESS randomised trial

Authors' conclusion

Documented history of CKD may modify the renal response to high-MAP targeting in elderly patients with septic shock. High-MAP targets were associated with fewer RRT-FD in patients without CKD.

Study context

Population
Patients aged ≥ 65 years with septic shock (70 with chronic kidney disease (CKD), 361 without)complete case analysis
Participants
431 patients
Comparison
High-MAP vs standard-MAP targets, by CKD status
Primary endpoint
RRT-free days (RRT-FD)
Follow-up
28 days
Methodological detailspost hoc, multicentre, subgroup analysis by CKD status, inverse probability of treatment weighting (IPTW) and multiple imputation sensitivity analysis
  • Post hoc
  • Multicentre
  • Subgroup analysis by CKD status
  • IPTW and multiple imputation sensitivity analysis

Primary result

As reported in the abstract

RRT-FD by CKD status (subgroup)

Adjusted β

- 3.5 days

95% CI - 5.94 to - 1.11

without CKD (n=361)

Adjusted β

+ 2.0 days

95% CI - 4.34 to + 8.35

with CKD (n=70); no significant association

Secondary outcomes

Major adverse kidney events (MAKE) at hospital discharge, by CKD status (subgroup)

Direction of effect consistent with renal replacement therapy-free days (RRT-FD); not statistically significant in patients without CKD

Sensitivity analysis (IPTW, multiple imputation)

Directionally consistent findings

Original publication

Effect modification by chronic kidney disease on renal outcomes in septic shock patients undergoing high-MAP targeting: a secondary analysis of the OPTPRESS trial. J Intensive Care. Published 18 April 2026. doi:10.1186/s40560-026-00882-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.